Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 86
Filter
1.
J Bone Miner Res ; 14(7): 1145-52, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10404014

ABSTRACT

Members of the transforming growth factor-beta (TGF-beta) family transduce signals from the cell membrane to the nucleus via specific type I and type II receptors and Smad proteins. Smad1 and Smad5 mediate intracellular signaling of bone morphogenetic protein (BMP), whereas Smad2 and Smad3 transduce TGF-beta signaling. Smad4 is a common mediator required for both pathways. Smad6 and Smad7 inhibit signaling by members of the TGF-beta superfamily. Here, we examined the expression of Smad1 to Smad7 proteins during endochondral ossification of epiphyseal plate of growing rats using immunohistochemical techniques. The expression of Smad proteins was correlated with the expression of TGF-beta1 and its receptors, and BMP-2/4 and BMP receptors. The results show that TGF-beta1 and BMP-2/4 were actively expressed in chondrocytes that are undergoing proliferation and maturation, which overlaps with expression of their corresponding type I and type II receptors. The Smads, however, exhibited a distinct expression pattern, respectively. For example, Smad1 and Smad5 were highly expressed in proliferating chondrocytes and in those chondrocytes that are undergoing maturation. The TGF-beta/activin-restricted Smads were also expressed in a nearly complementary fashion; Smad2 was strongly expressed in proliferating chondrocytes, whereas Smad3 was strongly observed in maturing chondrocytes. Smad4 was broadly expressed in all zones of epiphyseal plate. Inhibitory Smads, Smad6 and Smad7, were strongly expressed in the zone of cartilage that contained mature chondrocytes. Our findings show a colocalization of the pathway-restricted and inhibitory Smads with activating ligands or ligands whose action they antagonize and their receptors in various zones of epiphyseal growth plate, suggesting that TGF-beta superfamily Smad signaling pathways plays a morphogenic role during endochondral bone formation.


Subject(s)
Activin Receptors, Type I , DNA-Binding Proteins/metabolism , Growth Plate/metabolism , Osteogenesis/physiology , Second Messenger Systems/physiology , Trans-Activators/metabolism , Transforming Growth Factor beta/metabolism , Animals , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Bone Morphogenetic Protein Receptors, Type I , Bone Morphogenetic Protein Receptors, Type II , Bone Morphogenetic Proteins/metabolism , Cell Nucleus/metabolism , Chondrocytes/metabolism , Growth Plate/physiology , Immunohistochemistry , Protein Serine-Threonine Kinases/metabolism , Rats , Rats, Wistar , Receptor, Transforming Growth Factor-beta Type I , Receptor, Transforming Growth Factor-beta Type II , Receptors, Growth Factor/metabolism , Receptors, Transforming Growth Factor beta/metabolism
2.
J Bone Miner Res ; 14(4): 500-8, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10234570

ABSTRACT

Ossification of the posterior longitudinal ligament of the spine (OPLL) is characterized by ectopic bone formation in the ligament. OPLL is a very common disorder, in fact it constitutes the leading cause of myelopathy among Japanese. In the previous report, we provided the genetic linkage evidence that the genetic susceptibility of OPLL mapped to HLA complex of chromosome 6. As a candidate gene approach, retinoic X receptor beta (RXR beta), assigned to chromosome 6p21.3 adjacent to HLA class II, was analyzed for a possible causality. To start screening for the molecular variants of RXR beta in OPLL subjects, we first obtained P1 phage genomic clones containing the entire human RXR beta and elucidated the genomic organization of the gene. The human RXR beta is composed of 10 exons spanning over 6.2 kb of genomic DNA. Sequence analysis of the promoter region revealed a GC-rich sequence without TATA motif. We have identified three distinct molecular variants, one was in exon 10 and two were in the intergenic region between RXR beta and collagen 11A2 (COL11A2). Two variants in the intergenic region, 3' end + 140 and 3' end + 561, exhibit statistically significant associations with OPLL in case-control study (p = 0.0028 for 3' end + 140 and p = 0.034 for 3' end + 561). These results indicate that the genetic causality of OPLL lies within or close to the RXR beta/COL11A2 locus.


Subject(s)
Mutation , Ossification of Posterior Longitudinal Ligament/genetics , Receptors, Retinoic Acid/genetics , Transcription Factors/genetics , Adult , Aged , Aged, 80 and over , Alleles , Base Sequence , Case-Control Studies , Cells, Cultured , DNA Mutational Analysis , DNA Primers/genetics , Exons , Female , Gene Frequency , Genetic Variation , Haplotypes , Humans , Introns , Ligaments/metabolism , Male , Middle Aged , Molecular Sequence Data , Promoter Regions, Genetic , Retinoid X Receptors
3.
J Bone Miner Res ; 10(11): 1651-9, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8592941

ABSTRACT

Type I receptors for bone morphogenetic proteins (BMPs), i.e., BMPR-IA and BMPR-IB, are transmembrane serine/threonine kinases, that bind osteogenic protein-1 (OP-1, also termed BMP-7) and BMP-4. Using antibodies specific to BMPR-IA and -IB, we have studied the expression of BMP type I receptors in the bone formation process during embryonic development and fracture healing. In the mouse embryo, both BMPR-IA and -IB were expressed in condensing mesenchymal cells at 13.5 days post coitum (p.c.). At 15.5 days p.c., expression of BMPR-IB, but not of BMPR-IA, was observed in the cells in perichondrium of developing cartilage. At 17.5 and 19.5 days p.c., expression of both receptors was observed in chondrocytes and in osteoblasts. In normal rat adult bone, expression of BMPR-IA, but not of BMPR-IB, was observed in osteoblasts in the periosteum. Three days after the femoral fracture, expression of BMPR-IA and -IB was up-regulated in cells at the proliferating osteogenic layer of the periosteum. On day 7, both receptors were found in fibroblast-like spindle cells and chondrocytes in the endochondral ossification sites, and osteoblasts in the newly formed trabecular bone. Expression of BMPR-IA was higher than that BMPR-IB in osteogenic layer on day 3 and in osteoblasts in the trabecular bone on day 7. On day 14, expression of BMP type I receptors was observed at similar sites, albeit with lower expression levels than were observed on day 7. The present data suggest that expression of BMP type I receptors is up-regulated during bone formation, and that they may play important roles in bone morphogenesis.


Subject(s)
Bone Development/physiology , Growth Substances/genetics , Proteins/genetics , Receptors, Cell Surface/genetics , Receptors, Growth Factor , Animals , Antibodies , Bone Morphogenetic Protein Receptors , Bone Morphogenetic Protein Receptors, Type I , Bone Morphogenetic Proteins , Femoral Fractures/metabolism , Femoral Fractures/pathology , Fibroblasts/cytology , Fibroblasts/metabolism , Growth Substances/metabolism , Immunohistochemistry , Mice , Mice, Inbred C57BL , Osteoblasts/cytology , Osteoblasts/metabolism , Proteins/metabolism , Rats , Rats, Wistar , Receptors, Cell Surface/metabolism , Tissue Fixation
4.
J Bone Miner Res ; 16(5): 948-57, 2001 May.
Article in English | MEDLINE | ID: mdl-11341341

ABSTRACT

Ossification of the posterior longitudinal ligament (OPLL) of the spine is the leading cause of myelopathy in Japan. In earlier studies, we provided genetic linkage and allelic association evidence of distinct differences in the human collagen alpha2(XI) gene (COL11A2) that might constitute inherited predisposition to OPLL. In the present study, a strong allelic association with non-OPLL (p = 0.0003) was observed with an intron 6 polymorphism [intron 6 (-4A)], in which the intron 6 (-4A) allele is more frequently observed in non-OPLL subjects than in OPLL patients. In addition, a newly identified polymorphism in exon 6 [exon 6 (+28A)] was in linkage disequilibrium with the intron 6 (-4A). The functional impact of the polymorphisms was analyzed by comparing the differences in messenger RNA (mRNA) splicing by reverse-transcription polymerase chain reaction (RT-PCR) analysis in cultured cells from the interspinous ligament and an in vitro exon trapping study. The intron 6 (-4A) allele resulted in skipping exon 6 and retaining exon 7, while the exon 6 (+28A) allele was not associated with alteration in mRNA splicing. Similar mRNA species were observed in undifferentiated osteoblast (Ob) cells and in cells from posterior longitudinal ligament of non-OPLL subjects. The region containing exons 6-8 is an acidic subdomain presumably exposed to the surface that could interact with molecules of the extracellular matrix. Accordingly, retaining exon 7 together with removal of exon 6 observed in intron 6 (-4A) could play a protective role in the ectopic ossification process because the same pattern was observed in undifferentiated Ob cells and nonossified posterior longitudinal ligament cells.


Subject(s)
Collagen/genetics , Ossification of Posterior Longitudinal Ligament/pathology , Polymorphism, Genetic , Spine/pathology , Alternative Splicing , Amino Acid Sequence , Cell Culture Techniques , Cell Differentiation , Cells, Cultured , Collagen/physiology , Exons , Humans , Introns , Linkage Disequilibrium , Molecular Sequence Data , Ossification of Posterior Longitudinal Ligament/genetics , Osteoblasts/cytology , RNA, Messenger
5.
J Neuropathol Exp Neurol ; 58(5): 442-50, 1999 May.
Article in English | MEDLINE | ID: mdl-10331432

ABSTRACT

The aims of this study were to clarify the mechanism of cell death by apoptosis in the spinal cord after traumatic injury, and to examine the role of the mitogen-activated protein kinase (MAPK) pathways in the transmission of apoptosis signals. The rat spinal cord, experimentally injured by extradural static weight-compression, was studied by hematoxylin and eosin staining, Nissl-staining, terminal deoxynucleotidyl transferase (TdT) mediated dUTP nick-end labeling (TUNEL) staining, and immunostaining using polyclonal antibodies against Apoptosis Signal-regulating Kinase 1 (ASK1), c-Jun N-terminal kinase (JNK), and p38 MAPK. TUNEL-positive cells were present at all stages studied until 7 days after injury, and percentage positivity for these cells was maximal at 3 days after injury. Electron microscopic analysis revealed the occurrence of apoptosis in both neuronal cells and glial cells. TUNEL-positive glial cells were stained by oligodendrocyte-specific maker. Expression of ASK1 was maximal at 24 h after injury in the gray matter and at 3 days after injury in the white matter. Following the expression of ASK1, activated forms of JNK and p38 were observed in apoptotic cells detected by the TUNEL method. Colocalization of ASK1 and activated JNK or activated p38 was observed in the same cell. These findings suggest the involvement of the stress-activated MAPK pathways including ASK1 in the transmission of apoptosis signals after spinal cord injury.


Subject(s)
Apoptosis/physiology , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , JNK Mitogen-Activated Protein Kinases , Mitogen-Activated Protein Kinase Kinases , Mitogen-Activated Protein Kinases , Protein Kinases/metabolism , Protein Serine-Threonine Kinases/metabolism , Spinal Cord Injuries/metabolism , Animals , Antibodies , Calcium-Calmodulin-Dependent Protein Kinases/analysis , Calcium-Calmodulin-Dependent Protein Kinases/immunology , In Situ Nick-End Labeling , MAP Kinase Kinase 4 , MAP Kinase Kinase Kinases , Male , Microscopy, Electron , Neurons/cytology , Neurons/enzymology , Neurons/ultrastructure , Protein Kinases/analysis , Protein Kinases/immunology , Protein Serine-Threonine Kinases/analysis , Protein Serine-Threonine Kinases/immunology , Rats , Rats, Wistar , Signal Transduction/physiology , p38 Mitogen-Activated Protein Kinases
6.
Bone ; 21(2): 155-62, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9267691

ABSTRACT

To elucidate the process of ossification in spinal ligaments, an aqueous solution containing recombinant human bone morphogenetic protein (BMP)-2 (40 micrograms/100 microL) was injected into murine ligamenta flava, and the ossification process was analyzed morphologically. In the control group, the solution administered lacked the protein; these flattened ligamentous fibroblasts possessing BMP receptors type IA and type II existed among type I collagen bundles. In the week immediately following the injection of BMP-2, ligamentous fibroblasts began to proliferate, differentiating into alkaline phosphatase-positive chondrocytes surrounded by an extracellular matrix composed of type I and II collagen. By the second week, differentiated chondrocytes of various stages were observed in type II collagen-rich matrix. These chondrocytes showed an abundance of BMP receptors type IA and II. The pathologically induced cartilage was resorbed by chondroclasts, permitting migration of blood vessels and osteogenic cells, as well as providing a site for endochondral ossification. By the third week, BMP-induced ossification had compressed the spinal cord, and by the sixth week, the ligamentous tissue had been almost completely replaced by bone. Ligamentous fibroblasts appeared to possess BMP receptors, as well as the potentiality to differentiate into chondrocytes. BMP receptors were upregulated during chondrification of ligamentous fibroblasts induced by exogenous BMP-2, suggesting that BMPs may play an important role in ossification of spinal ligaments.


Subject(s)
Bone Morphogenetic Proteins , Calcinosis/chemically induced , Cartilage/pathology , Ligamentum Flavum/pathology , Transforming Growth Factor beta , Acid Phosphatase/analysis , Animals , Biomarkers/analysis , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein Receptors, Type I , Bone Morphogenetic Protein Receptors, Type II , Calcinosis/metabolism , Calcinosis/pathology , Cartilage/ultrastructure , Cell Differentiation/drug effects , Collagen/metabolism , Extracellular Matrix/metabolism , Fibroblasts/drug effects , Fibroblasts/ultrastructure , Humans , Immunohistochemistry , Isoenzymes/analysis , Ligamentum Flavum/drug effects , Ligamentum Flavum/metabolism , Lumbar Vertebrae/metabolism , Lumbar Vertebrae/pathology , Male , Mice , Protein Serine-Threonine Kinases/analysis , Receptors, Growth Factor/analysis , Recombinant Proteins , Ribonucleases/analysis , Tartrate-Resistant Acid Phosphatase
7.
Bone ; 23(2): 147-53, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9701474

ABSTRACT

This study was designed to assess the effects of exercise training (Tr) following an etidronate treatment (E) on bone mineral density (BMD) of the femur and trabecular bone of the tibia in ovariectomized (ovx) rats. Female Wistar rats were ovariectomized (ovx) or sham-operated (sham) at 15 weeks of age and divided into five experimental groups: sham; ovx; ovx + E; ovx + Tr; ovx + E + Tr. Etidronate treatment of 5 mg/kg, 5 days/week was administered for 2 weeks and exercised on a treadmill for 30 m/min, 60 min/day, 5 days/week for 10 weeks. BMD of the femur and the trabecular bone area of the proximal tibia were significantly (p < 0.05) higher in E and/or Tr compared to ovx groups. However, the cortical region was not affected significantly by ovariectomy. The area partially filled with the trabecular bone at the constant width was observed only in the E rats. The number of osteoclasts in E group was significantly lower (p < 0.05) than in the ovx and ovx + Tr groups. The ovx + Tr rats had a higher number of osteoblasts (p < 0.05) than the ovx and ovx + E groups. There was a significant interaction between ovx + Tr and ovx + E on BMD in the proximal region of the femur (p < 0.05) and trabecular bone area of the tibia (p < 0.001). These results suggest that the etidronate treatment for 2 weeks beforehand influenced the effects of subsequent exercise training on maintaining the BMD in the proximal femur and the trabecular bone area of the tibia.


Subject(s)
Bone Density/drug effects , Etidronic Acid/pharmacology , Physical Conditioning, Animal , Absorptiometry, Photon , Animals , Disease Models, Animal , Etidronic Acid/administration & dosage , Female , Femur , Humans , Osteoporosis, Postmenopausal/diagnostic imaging , Osteoporosis, Postmenopausal/prevention & control , Ovariectomy , Rats , Rats, Wistar , Tibia
8.
Bone ; 22(6): 605-12, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9626398

ABSTRACT

Bone morphogenetic proteins (BMPs) and their receptors (BMPRs) are thought to play an important role in bone morphogenesis. The purpose of this study was to determine the locations of BMP-2/-4, osteogenic protein-1 (OP-1, also termed BMP-7), and BMP type II receptor (BMPR-II) during rat fracture healing by immunostaining, and thereby elucidate the possible roles of the BMPs and BMPR-II in intramembranous ossification and endochondral ossification. In the early stage of fracture repair, the expression of BMP-2/-4 and OP-1 was strongly induced in the thickened periosteum near the fracture ends, and coincided with an enhanced expression of BMPR-II. On day 7 after fracture, staining for BMP-2/-4 and OP-1 immunostaining was increased in various types of chondrocytes, and was strong in fibroblast-like spindle cells and proliferating chondrocytes in endochondral bone. On day 14 after fracture, staining with OP-1 antibody disappeared in proliferating and mature chondrocytes, while BMP-2/-4 staining continued in various types of chondrocytes until the late stage. In the newly formed trabecular bone, BMP-2/-4 and OP-1 were present at various levels. BMPR-II was actively expressed in both intramembranous ossification and endochondral ossification. Additionally, immunostaining for BMP-2/-4 and OP-1 was observed in multinucleated osteoclast-like cells on the newly formed trabecular bone, along with BMPR-II. In reference to our previous study of BMP type I receptors (BMPR-IA and BMPR-IB), BMPR-II was found to be co-localized with BMPR-IA and BMPR-IB. BMP-2/-4 and OP-1 antibodies exhibited distinct and overlapping immunostaining patterns during fracture repair. OP-1 may act predominantly in the initial phase of endochondral ossification, while BMP-2/-4 acts throughout this process. Thus, these findings suggested that BMPs acting through their BMP receptors may play major roles in modulating the sequential events leading to bone formation.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Fracture Healing/physiology , Protein Serine-Threonine Kinases/metabolism , Transforming Growth Factor beta/metabolism , Animals , Bone Morphogenetic Protein 7 , Bone Morphogenetic Protein Receptors, Type II , Bone Morphogenetic Proteins/biosynthesis , Calcification, Physiologic/physiology , Cell Division , Chondrocytes/metabolism , Fibroblasts/metabolism , Immunohistochemistry , Osteoblasts/metabolism , Osteoclasts/metabolism , Protein Serine-Threonine Kinases/biosynthesis , Rats , Rats, Wistar , Transforming Growth Factor beta/biosynthesis
9.
Bone ; 21(1): 23-30, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9213004

ABSTRACT

To clarify the pathogenesis of ossification of the ligamentum flavum (OLF), we examined the expression and localization of bone morphogenetic proteins (BMPs) and their receptors (BMPRs) in the ligamentum flavum of the patients with OLF by immunohistochemical staining and compared them with staining patterns in control patients. The BMPRs appeared extensively in mature and immature chondrocytes around the calcified zone and in spindle-shaped cells and round cells in the remote part from ossified foci in examined tissue of OLF. The ligands for BMPRs, BMP-2/-4 and osteogenic protein-1 (OP-1)/BMP-7, colocalized in OLF patients. In the control cases, expression of BMPs and BMPRs was observed around the calcified zone at the insertion of the ligamentum flavum to the bone, and limited expression was found in the smaller range. Thus, the expression profile of BMPs and BMPRs in OLF patients was entirely different from the control patients, suggesting that BMPs may be involved in promoting endochondral ossification at ectopic ossification sites in OLF, and that ossification activity is continuous in these patients.


Subject(s)
Bone Morphogenetic Proteins/biosynthesis , Calcinosis/genetics , Ligamentum Flavum/metabolism , Receptors, Cell Surface/metabolism , Activin Receptors , Adult , Aged , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Bone Morphogenetic Protein 7 , Bone Morphogenetic Protein Receptors , Bone Morphogenetic Proteins/genetics , Bone Morphogenetic Proteins/metabolism , Calcinosis/metabolism , Cartilage/cytology , Cartilage/metabolism , Cell Size/physiology , Female , Humans , Immunohistochemistry , Ligamentum Flavum/pathology , Ligamentum Flavum/physiology , Male , Middle Aged , Protein Serine-Threonine Kinases/metabolism , Radioligand Assay , Receptors, Growth Factor/metabolism , Transforming Growth Factor beta/metabolism
10.
Infect Control Hosp Epidemiol ; 19(2): 107-9, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9510109

ABSTRACT

The incidence and circumstances of colonization by methicillin-resistant Staphylococcus aureus were prospectively investigated. Among 404 patients, 15 (3.7%) were carriers on admission, and 43 (10.6%) became colonized, mainly after surgical operation. A different mode of transmission was suggested in each ward.


Subject(s)
Cross Infection/transmission , Hospital Departments , Methicillin Resistance , Staphylococcal Infections/transmission , Staphylococcus aureus , Adult , Aged , Child , Cross Infection/etiology , Hospitals, University , Humans , Incidence , Infection Control , Japan , Middle Aged , Orthopedics , Pediatrics , Prospective Studies , Risk Factors , Staphylococcal Infections/etiology , Surgery Department, Hospital
11.
J Appl Physiol (1985) ; 84(6): 1943-51, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9609788

ABSTRACT

The purpose of this study was to investigate the functional interrelationship between synergistic muscle activities during low-level fatiguing contractions. Six human subjects performed static and dynamic contractions at an ankle joint angle of 110 degrees plantar flexion and within the range of 90-110 degrees (anatomic position = 90 degrees) under constant load (10% maximal voluntary contraction) for 210 min. Surface electromyogram records from lateral gastrocnemius (LG), medial gastrocnemius (MG), and soleus (Sol) muscles showed high and silent activities alternately in the three muscles and a complementary and alternate activity between muscles in the time course. In the second half of all exercise times, the number of changes in activity increased significantly (P < 0.05) in each muscle. The ratios of active to silent periods of electromyogram activity were significantly higher (P < 0.05) in MG (4.5 +/- 2.2) and Sol (4.3 +/- 2.8) than in the LG (0.4 +/- 0.1), but no significant differences were observed between MG and Sol. These results suggest that the relative activation of synergistic motor pools are not constant during a low-level fatiguing task.


Subject(s)
Muscle, Skeletal/physiology , Adult , Electromyography , Exercise , Humans , Male , Motor Neurons/physiology , Muscle Contraction/physiology , Muscle Fatigue/physiology , Muscle, Skeletal/cytology , Muscle, Skeletal/innervation
12.
Brain Res ; 921(1-2): 219-25, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-11720729

ABSTRACT

It has been reported that bone morphogenetic proteins (BMPs) are involved in the generation of the central nervous system during development. However, the roles of BMPs in mature spinal cord have not been clarified. We examined the expression of BMP7 mRNA before and after traumatic injury of the adult rat spinal cord. BMP7 mRNA was already detectable at a relatively low level in uninjured spinal cord, but was dramatically increased after injury. Semiquantitative RT-PCR study further confirmed upregulation of BMP7 mRNA in injured spinal cord. In situ hybridization indicated that expression of BMP7 mRNA was present only in glial cells in uninjured spinal cord. After injury, the number of BMP7-expressing glial cells was increased, BMP7 expression also became apparent in motor neurons. It has been suggested that BMPs promote survival of subventricular zone cells in adult rats. Thus, our results suggest that increase in the expression of BMP7 promotes survival of neurons and glial cells after acute traumatic injury. In contrast, there is increasing evidence that BMPs inhibit neurogenesis and alternatively promote gliogenesis of neural progenitors, which are also present in adult spinal cord, suggesting that injury-upregulated BMP7 may regulate differentiation of glial cells from neural progenitors and may induce gliosis after central nervous system injury.


Subject(s)
Bone Morphogenetic Proteins/genetics , Neuroglia/metabolism , Neurons/metabolism , RNA, Messenger/metabolism , Spinal Cord Injuries/metabolism , Spinal Cord/metabolism , Transforming Growth Factor beta , Up-Regulation/genetics , Age Factors , Alternative Splicing/genetics , Animals , Bone Morphogenetic Protein 7 , Cell Division/genetics , Cell Survival/genetics , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Male , Nerve Regeneration/genetics , Neuroglia/cytology , Neurons/cytology , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Spinal Cord/cytology , Spinal Cord Injuries/genetics , Spinal Cord Injuries/physiopathology , Stem Cells/cytology , Stem Cells/metabolism
13.
J Orthop Res ; 16(3): 314-21, 1998 May.
Article in English | MEDLINE | ID: mdl-9671926

ABSTRACT

Activins are multifunctional proteins that belong to the transforming growth factor-beta superfamily and are thought to play an important role in modulating the formation of bone. Activins exert their cellular effects by way of activin type-I and type-II serine/threonine kinase receptors. Follistatin is an activin-binding protein that can suppress the biological effects of activins. In this study, the immunohistochemical expression of activin A, follistatin, and activin receptors was studied during fracture healing in the rat. Activin A was weakly detected in the periosteum near the fracture ends at an early stage but was absent in the chondrocytes around the fracture gap, where endochondral ossification took place. An antibody to follistatin stained osteogenic cells in the periosteum near the fracture ends; moderate and strong staining were observed in proliferating, mature, and hypertrophied chondrocytes at the sites of endochondral ossification. Levels of activin A and follistatin were high near the osteoblasts on the surface of the newly formed trabecular bone. In addition, an intense localization of activin A was noted where multinucleated osteoclast-like cells were present. This study suggests that the activin-follistatin system may contribute to cellular events related to the formation and remodeling of bone during fracture healing. Activin type-I and type-II receptors were co-expressed in intramembranous and endochondral ossification sites. The expression of activin type-I, type-II, and type-IIB receptors in the absence of activin A in the endochondral ossification suggests that other isoforms of activins may signal by way of these receptors.


Subject(s)
Fracture Healing , Glycoproteins/analysis , Inhibins/analysis , Receptors, Growth Factor/analysis , Activin Receptors , Activins , Animals , Follistatin , Glycoproteins/physiology , Immunohistochemistry , Inhibins/physiology , Mice , Mice, Inbred BALB C , Rabbits , Rats , Rats, Wistar , Receptors, Growth Factor/physiology
14.
J Orthop Res ; 15(6): 820-9, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9497806

ABSTRACT

Ossification of the posterior longitudinal ligament is a human genetic disease in which pathological ectopic ossification of the spinal ligaments develops. This leads to myelopathy or radiculopathy due to compression of the spinal cord. In this study, we investigated the histological features of orthotopic ossification of the spinal ligaments of senile Zucker fatty rats. A remarkably high incidence of orthotopic ossification was observed mainly in the thoracic spinal ligaments as compared with controls. The histopathological findings were similar to those for ossification of the human posterior longitudinal ligament. Bone morphogenetic proteins and activins, which exert their effects by way of specific type-I and type-II serine/threonine kinase receptors, play important roles in the formation of bone and cartilage. In the spinal ligaments of Zucker fatty rats, bone morphogenetic protein receptors and activin receptors were immunohistochemically detected around the ossified foci in a manner similar to that previously shown for the ossified tissue from patients who had ossification of the posterior longitudinal ligament. Thus, bone morphogenetic proteins and activin receptors might play important roles in orthotopic ossification of the spinal ligaments of Zucker fatty rats as well as in ossification of the posterior longitudinal ligament of humans. In addition, bone morphogenetic protein-receptor-IA was expressed in the nonossified ligament, suggesting that the spinal ligaments, of the rats may have a predisposition to orthotopic ossification. In the controls, no expression of bone morphogenetic protein receptors or of activin receptors was observed. In conclusion, there is a great degree of similarity between orthotopic ossification of the spinal ligaments of Zucker fatty rats and ossification of the posterior longitudinal ligament of humans. Thus, the rats provide a useful animal model for the study of ossification of the human posterior longitudinal ligament.


Subject(s)
Longitudinal Ligaments/pathology , Ossification of Posterior Longitudinal Ligament/pathology , Ossification, Heterotopic/pathology , Transforming Growth Factor beta , Activin Receptors , Aged , Animals , Bone Morphogenetic Protein 7 , Bone Morphogenetic Protein Receptors , Bone Morphogenetic Proteins/metabolism , Disease Models, Animal , Female , Humans , Immunohistochemistry , Longitudinal Ligaments/diagnostic imaging , Longitudinal Ligaments/metabolism , Male , Middle Aged , Ossification of Posterior Longitudinal Ligament/diagnostic imaging , Ossification of Posterior Longitudinal Ligament/metabolism , Ossification, Heterotopic/diagnostic imaging , Ossification, Heterotopic/metabolism , Radiography , Rats , Rats, Zucker , Receptors, Cell Surface/metabolism , Receptors, Growth Factor/metabolism
15.
J Neurosurg ; 83(5): 884-8, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7472559

ABSTRACT

To clarify the role of N-methyl-D-aspartate (NMDA) receptors in acute spinal cord injury, changes in the intraspinal microcirculation after acute spinal cord injury in rabbits were examined. Systemic administration of MK-801, an NMDA receptor antagonist, at a dose of 5 mg/kg, significantly improved motor recovery after injury and significantly reduced edema formation at the injured site without altering spinal cord blood flow or vascular permeability at the injured site. These findings indicate that excitatory amino acids contribute to secondary spinal cord damage, especially edema formation, mediated by NMDA receptors in the early stage after injury.


Subject(s)
Receptors, N-Methyl-D-Aspartate/physiology , Spinal Cord Injuries/metabolism , Acute Disease , Animals , Blood Pressure/drug effects , Capillary Permeability/drug effects , Dizocilpine Maleate/pharmacology , Edema/etiology , Edema/prevention & control , Excitatory Amino Acid Antagonists/pharmacology , Microcirculation/drug effects , Rabbits , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Regional Blood Flow/drug effects , Spinal Cord/blood supply , Spinal Cord Diseases/etiology , Spinal Cord Diseases/prevention & control , Spinal Cord Injuries/complications , Spinal Cord Injuries/physiopathology
16.
J Neurosurg ; 91(1 Suppl): 98-104, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10419375

ABSTRACT

OBJECT: The aims of this study were to clarify the histological and histochemical changes associated with cell death in the spinal cord after acute traumatic injury and to examine the role of excitatory amino acid release mediated by N-methyl-D-aspartate (NMDA) receptors. METHODS: Following laminectomy, the spinal cord in 70 rats was injured at the T-9 level by applying extradural static weight-compression, in which a cylindrical compressor was used to induce complete and irreversible transverse spinal cord injury (SCI) with paralysis of the lower extremities. The injured rats were killed between 30 minutes and 14 days after injury, and the injured cord was removed en bloc. Rats that received NMDA receptor antagonist (MK-801) were killed at the same time points as those that received saline. The specimens were stained with hematoxylin and eosin, Nissl, and Klüver-Barrera Luxol fast blue and subjected to in situ nick-end labeling, a specific in situ method used to allow visualization of apoptosis. Thirty minutes post-SCI, a large hematoma was observed at the compressed segment. Six hours after injury, large numbers of dead cells that were not stained by in situ nick-end labeling were observed. Between 12 hours and 14 days postinjury, nuclei stained by using the in situ nick-end labeling technique were observed not only at the injury site but also in adjoining segments that had not undergone mechanical compression, suggesting that the delayed cell death was due to apoptosis. The number of cells stained by in situ nick-end labeling was maximum at 3 days postinjury. The results of electron microscopic examination were also consistent with apoptosis. In the MK-801-treated rats, the number of cells stained by in situ nick-end labeling was smaller than in nontreated rats at both 24 hours and 7 days after injury. CONCLUSIONS: These findings suggest that NMDA-receptor activation promotes delayed neuronal and glial cell death due to apoptosis.


Subject(s)
Apoptosis , Dizocilpine Maleate/therapeutic use , Excitatory Amino Acid Antagonists/therapeutic use , Neuroprotective Agents/therapeutic use , Spinal Cord Injuries/pathology , Animals , Apoptosis/drug effects , Cell Count , Cell Death , Cell Nucleus/ultrastructure , Coloring Agents , Demyelinating Diseases/drug therapy , Demyelinating Diseases/pathology , Dizocilpine Maleate/administration & dosage , Excitatory Amino Acid Antagonists/administration & dosage , Fluorescent Dyes , Hematoma/pathology , In Situ Nick-End Labeling , Laminectomy , Male , Microscopy, Electron , N-Methylaspartate/antagonists & inhibitors , Nerve Fibers, Myelinated/drug effects , Nerve Fibers, Myelinated/pathology , Neurons/ultrastructure , Neuroprotective Agents/administration & dosage , Paralysis/drug therapy , Paralysis/pathology , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Spinal Cord Compression/pathology , Spinal Cord Injuries/drug therapy
17.
Anticancer Res ; 20(6C): 4681-6, 2000.
Article in English | MEDLINE | ID: mdl-11205200

ABSTRACT

PURPOSE: To investigate the optimal duration of oral HCFU administration for minimization of side effects induced by long-term administration. PATIENTS AND METHODS: In total, 155 patients allocated to two groups of different duration of the therapy were reviewed: twice or three times per day doses of oral HCFU (8 mg/Kg body weight/day) for 3 months vs. 12 months. RESULTS: Though statistically significant difference was not found in cumulative survival and disease-free rates between the groups due to so many violations of duration of therapy, when reanalyzing the variables in order of real duration of therapy, those rates were significantly higher in patients treated for 300 and more days than less than 300 days (g-Wilcoxon test: p < 0.04). No significant difference was observed in the background factors between the groups. CONCLUSION: At least 300 days is suggested to be necessary to obtain the optimal effectiveness of adjuvant chemotherapy for curatively resected colorectal cancer.


Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Colonic Neoplasms/drug therapy , Colonic Neoplasms/surgery , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/surgery , Fluorouracil/therapeutic use , Rectal Neoplasms/drug therapy , Rectal Neoplasms/surgery , Administration, Oral , Adult , Aged , Antimetabolites, Antineoplastic/administration & dosage , Colonic Neoplasms/mortality , Colonic Neoplasms/pathology , Colorectal Neoplasms/mortality , Colorectal Neoplasms/pathology , Disease-Free Survival , Drug Administration Schedule , Female , Fluorouracil/administration & dosage , Follow-Up Studies , Humans , Male , Middle Aged , Rectal Neoplasms/mortality , Rectal Neoplasms/pathology , Retrospective Studies , Survival Rate , Time Factors
18.
Anticancer Res ; 16(5A): 2853-6, 1996.
Article in English | MEDLINE | ID: mdl-8917397

ABSTRACT

Electromagnetic stimulation is known to promote bone formation in cases of fracture and pseudoarthrosis. The possibility of using electromagnetic field to promote bone ingrowth into a porous coated implant was investigated in this study using Japanese albino rabbits. A titanium implant coated with beads of 250-300 microns in diameter around a stem of 1.7 mm in diameter was inserted into the humerus cavity of a Japanese albino rabbit. The humerus was stimulated by pulsing electromagnetic fields at 2 Gauss, 10Hz, 25 microseconds for 14 days. The circumference of grown bone into the implant was measured, and calculated in area equivalent for determination of the area of new bone. Bone ingrowth was significantly promoted by consecutive 14 days. The result suggests that electromagnetic stimulation is useful for achieving further bone ingrowth into a porous coated implant.


Subject(s)
Electromagnetic Fields , Osseointegration/physiology , Animals , Electric Stimulation , Male , Prostheses and Implants , Rabbits , Titanium
19.
Anticancer Res ; 18(6A): 4189-93, 1998.
Article in English | MEDLINE | ID: mdl-9891466

ABSTRACT

The activities of TGF-beta s and their receptors (T beta R) in the articular cartilage have not been fully elucidated as yet. Temporal and spatial expression of TGF-beta s and their receptors were examined immunohistochemically in the articular cartilage of growing rats to clarify their role in chondrogenesis. TGF-beta 1, -beta 2 and -beta 3 were strongly expressed from 6 to 50 weeks in the superficial, transitional, and least mature zones. The expression of TGF-beta s in hypertrophic chondrocyte was weak except TGF-beta 1. T beta R-I and T beta R-II were co-expressed with the ligand in the superficial, transitional, and least mature zones throughout the growth phase. This study revealed that TGF-beta s in the articular cartilage plays a major role in the modulation of endochondral ossification ensuring the growth and maintenance of the chondrocyte lineage in articular cartilage.


Subject(s)
Activin Receptors, Type I , Aging/metabolism , Cartilage, Articular/metabolism , Protein Serine-Threonine Kinases/genetics , Receptors, Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/genetics , Animals , Cartilage, Articular/cytology , Cartilage, Articular/growth & development , Gene Expression Regulation, Developmental , Immunohistochemistry/methods , Male , Osteoblasts/cytology , Osteoblasts/metabolism , Protein Serine-Threonine Kinases/analysis , Rats , Rats, Wistar , Receptor, Transforming Growth Factor-beta Type I , Receptor, Transforming Growth Factor-beta Type II , Receptors, Transforming Growth Factor beta/analysis , Transforming Growth Factor beta/analysis
20.
Anticancer Res ; 18(4A): 2339-44, 1998.
Article in English | MEDLINE | ID: mdl-9703876

ABSTRACT

The expression of bone morphogenetic proteins (BMPs) and BMP receptors (BMPRs) in the epiphyseal growth plate has not been clarified. In this study, we studied immunohistochemically the spatial and temporal localization of BMP-2/4, osteogenic protein-1 (OP-1, or BMP-7), and BMP receptors (BMPR-IA, BMPR-IB, and BMPR-II) in the epiphyseal plate of growing rats. The proximal parts of tibia in growing rats were observed. At 12 weeks after birth, BMP-2/4 and OP-1 were expressed markedly in proliferating and maturing chondrocytes. BMPR-IA, IB and II were clearly co-expressed in proliferating and maturing chondrocytes, and the expression was decreased in hypertrophic chondrocytes. At 24 weeks, the expression of BMP-2/4 and OP-1 was decreased, but BMPRs were still well-expressed in proliferating chondrocytes. The temporal and spatial expression of BMP and BMPR suggests that BMP and BMP receptors play roles in the multistep cascade of enchondral ossification in the epiphyseal growth plate.


Subject(s)
Aging/metabolism , Bone Morphogenetic Proteins/biosynthesis , Growth Plate/metabolism , Receptors, Cell Surface/biosynthesis , Receptors, Growth Factor , Animals , Animals, Newborn , Bone Morphogenetic Protein Receptors , Bone Morphogenetic Proteins/analysis , Cartilage, Articular/cytology , Cartilage, Articular/growth & development , Cartilage, Articular/metabolism , Cell Division , Growth Plate/cytology , Growth Plate/growth & development , Immunohistochemistry , Male , Osteogenesis , Rats , Rats, Wistar , Receptors, Cell Surface/analysis
SELECTION OF CITATIONS
SEARCH DETAIL